Tenet Healthcare operates a nationwide network of hospitals and other healthcare facilities, and also provides business process services to the healthcare industry.

• HCA Healthcare for diversified facilities: Think of it as HCA Healthcare, but operating an even broader network that includes hospitals, hundreds of ambulatory surgery centers, urgent care clinics, and imaging centers.
• HCA Healthcare meets R1 RCM: Imagine a company that operates a large portfolio of patient care facilities, similar to HCA Healthcare, but also has a significant division providing essential back-office services like revenue cycle management for other healthcare organizations, akin to R1 RCM.

• Hospital Acute Care Services: Comprehensive medical and surgical treatments provided in general hospitals, encompassing emergency care, specialized units, and various therapeutic services.
• Quaternary Care Services: Highly specialized and complex medical procedures such as organ transplants, advanced trauma care, and complex cardiovascular interventions.
• Ambulatory Surgery Centers: Facilities offering same-day surgical procedures that do not require an overnight hospital stay.
• Urgent Care Centers: Walk-in clinics providing immediate medical attention for illnesses and injuries that are not life-threatening.
• Diagnostic Imaging Services: Centers providing various imaging modalities like X-rays, CT scans, and MRIs for diagnostic purposes.
• Healthcare Business Process Services: Solutions for healthcare providers covering revenue cycle management, patient engagement, and value-based care optimization.

Tenet Healthcare (THC) primarily sells its healthcare services directly to **individuals**, who are its patients. Based on the services described, its major customer categories are:

1. Patients requiring hospital-based acute and specialized care: This category includes individuals seeking emergency services, critical care, complex surgical procedures (such as cardiothoracic surgery, complex spinal surgery, neurosurgery), and highly specialized treatments across various medical fields like cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics. It also encompasses patients requiring quaternary care services, including heart and kidney transplants, and level 1 trauma care.

2. Patients utilizing ambulatory and outpatient services: This group comprises individuals who receive care at Tenet's extensive network of ambulatory surgery centers, urgent care centers, imaging centers, surgical hospitals, off-campus emergency departments, and micro-hospitals. Services include physical therapy, minimally invasive cardiac valve replacement, and other outpatient procedures and diagnostic services.

3. Patients seeking general diagnostic and supportive care: This category covers individuals who utilize essential services within Tenet's facilities, such as clinical laboratories, pharmacies, radiology, and respiratory therapy services, for general medical needs, diagnostics, and ongoing support.

Saum Sutaria, M.D., Chairman and Chief Executive Officer

Dr. Saum Sutaria was appointed Chief Executive Officer of Tenet Healthcare in September 2021 and assumed the additional role of Chairman in 2023. Prior to this, he served as President and Chief Operating Officer, a position he took in January 2019. Before joining Tenet, Dr. Sutaria spent nearly two decades at McKinsey & Company, where he was a prominent leader in both the healthcare and private equity practices. In this role, he provided strategic, operational, and financial counsel to various clients. He also held an associate clinical faculty appointment at the University of California at San Francisco, focusing on internal medicine and cardiology after completing his postgraduate training there.

Sun Park, Executive Vice President and Chief Financial Officer

Sun Park was appointed Executive Vice President and Chief Financial Officer of Tenet Healthcare, effective January 1, 2024, succeeding the retiring Dan Cancelmi. Before his tenure at Tenet, Mr. Park served as Executive Vice President and Group Chief Financial Officer for Pharmaceutical Distribution and Strategic Global Sourcing at AmerisourceBergen, a global pharmaceutical sourcing and distribution services company. His prior experience also includes various leadership roles at MedImmune, AstraZeneca, and Merrill Lynch & Company.

Howard Hacker, Executive Vice President and Chief Compliance Officer

Howard Hacker was appointed Tenet Healthcare's Chief Compliance Officer in May 2016 and later became Executive Vice President in March 2019. In this role, he is responsible for overseeing the company's ethics and compliance programs. Before joining Tenet, Mr. Hacker spent more than a decade at Pfizer Inc., where he held various leadership positions within their legal and compliance teams, including Chief Compliance Counsel for Pfizer's Global Established Pharma business. Earlier in his career, he worked for the law firms of Jones Day and Akin Gump Strauss Hauer & Feld LLP, specializing in securities law and mergers and acquisitions.

Paola Arbour, Executive Vice President and Chief Information Officer

Paola Arbour serves as Tenet Healthcare's Executive Vice President and Chief Information Officer. She is responsible for the company's information technology strategy and operations. (Background details not extensively available in search results for specific founding/selling of companies or private equity patterns).

Tom Arnst, Executive Vice President, Chief Administrative Officer and General Counsel

Tom Arnst holds the positions of Executive Vice President, Chief Administrative Officer, General Counsel, and Corporate Secretary at Tenet Healthcare. (Background details not extensively available in search results for specific founding/selling of companies or private equity patterns).

Tenet Healthcare (THC) faces several key risks to its business operations and financial performance:

1. Changes in Healthcare Policy and Regulations: Tenet Healthcare is significantly exposed to potential changes in government healthcare policy and regulations. Revisions to the Affordable Care Act (ACA), for instance, could lead to a rise in uninsured patients, subsequently increasing the company's bad debt expenses. Proposed cuts to Medicaid funding and the ongoing debate surrounding site neutrality policies, which aim to standardize payments for services regardless of the care setting, could also adversely affect reimbursement rates, patient volumes, and the company's pricing strategy, particularly within its ambulatory surgery centers.

2. Labor Cost Pressures and Staffing Shortages: The company faces ongoing challenges in recruiting and retaining qualified healthcare professionals amidst nationwide shortages of medical support staff. This intense competition for talent, coupled with union activities and the need to offer competitive wages and benefits, contributes to increased operational costs and can impact overall profitability.

3. High Financial Leverage and Interest Rate Exposure: Tenet Healthcare operates with a significant debt load, characterized by a debt-to-equity ratio that is above the average for the broader Health Care Facilities industry. This high level of financial leverage exposes the company to risks associated with interest rate fluctuations, which can increase debt servicing costs. Furthermore, strategic growth initiatives, such as the expansion of its United Surgical Partners International (USPI) segment, necessitate substantial capital investment, further highlighting the importance of managing its debt profile effectively.

Tenet Healthcare Corporation faces clear emerging threats from two primary areas:

• Vertical Integration by Large Payers and Technology Companies: Major health insurance companies and large technology firms are increasingly acquiring or developing their own networks of providers, including primary care clinics, urgent care centers, and specialty practices. This trend creates integrated healthcare ecosystems that can direct patient flow within their own systems, potentially diverting patients away from Tenet's hospitals and ambulatory care facilities. These entities often have vast financial resources and technological capabilities to build comprehensive care delivery models, threatening Tenet's market share across its hospital and ambulatory segments, and potentially competing with its Conifer business process services if they develop robust in-house administrative solutions.
• Expansion of "Hospital-at-Home" Programs and Advanced Virtual Care Models: The growing adoption and reimbursement for "hospital-at-home" programs, which deliver acute-level care to patients in their homes, pose a direct threat to Tenet's traditional inpatient hospital segment. Coupled with the rapid advancements and acceptance of other advanced virtual care models for a broader range of conditions, these alternatives can reduce the necessity for physical hospital admissions and emergency department visits, thereby impacting Tenet's patient volume and revenue for its most capital-intensive assets.

Tenet Healthcare (THC) operates in several significant addressable markets within the United States.

Hospital Operations and Other

Tenet's Hospital Operations and Other segment, which includes general hospitals offering acute care and a variety of specialized services, addresses the broader U.S. hospital services market. This market was valued at approximately USD 3.23 trillion in 2024.

Ambulatory Care

The Ambulatory Care segment encompasses ambulatory surgery centers and urgent care centers.

• For ambulatory surgery centers, the U.S. Ambulatory Surgery Center market is estimated to be valued at USD 72.58 billion in 2025.
• The U.S. urgent care centers industry size was worth USD 75.1 billion in 2023.

Conifer

Tenet's Conifer segment provides healthcare business process services, primarily in revenue cycle management. The U.S. healthcare revenue cycle management market size is calculated at approximately USD 65.38 billion in 2025.

Tenet Healthcare (THC) is expected to drive future revenue growth over the next 2-3 years through several key strategies, primarily focusing on its Ambulatory Care segment and enhancing services within its Hospital Operations.

1. Expansion of the Ambulatory Care Segment (USPI): Tenet Healthcare is heavily focused on expanding its Ambulatory Care segment, United Surgical Partners International (USPI), through both strategic mergers and acquisitions (M&A) and the development of new de novo centers. The company plans to invest approximately $250 million annually in M&A within the ambulatory space and anticipates adding 10 to 12 new de novo centers in 2025. This aggressive expansion aims to capture a larger market share in outpatient services, aligning with broader healthcare trends favoring lower-cost, high-acuity surgical care in outpatient settings.
2. Increasing Higher-Acuity Procedures: A significant driver of revenue growth is Tenet's focus on increasing its capacity for higher-acuity procedures within its Ambulatory Surgery Centers (ASCs), such as total joint replacements, orthopedics, cardiology interventions, and neurosurgery. This strategy caters to evolving patient needs and is a key profitability driver for the company. Similarly, within its Hospital Operations segment, the company is investing in organic growth and higher-acuity service lines, including cardiac care, intensive care, high-end imaging, trauma, and invasive cancer surgery.
3. Strategic Partnerships for Market Expansion: Tenet is forming strategic partnerships to expand its Ambulatory Surgery Center network into new markets. For example, a collaboration with Providence, a 52-hospital system, aims to establish 15 to 20 new centers within two years, accelerating growth and extending Tenet's reach.
4. Leveraging Technology and AI in Revenue Cycle Management (Conifer): The Conifer segment is focusing on integrating advanced technologies and AI-driven workflows to optimize cash flow performance and improve patient engagement for its clients. Recent strategic transactions related to Conifer are expected to provide incremental earnings for Tenet and support Conifer's investments in artificial intelligence, automation, and global operating capabilities to enhance revenue cycle management services.

Share Repurchases

• Tenet Healthcare repurchased $1.386 billion of common stock in 2025.
• The company repurchased $672 million of common stock in 2024 and $200 million in 2023.
• As of July 22, 2025, Tenet Healthcare had $1.781 billion remaining under its share repurchase authorization, following a $1.5 billion increase.

Share Issuance

• The number of shares outstanding has consistently declined, with a 7.2% decrease in 2025 from 2024, a 6.6% decrease in 2024 from 2023, and a 5.17% decrease in 2023 from 2022, primarily due to share repurchases.

Outbound Investments

• Tenet Healthcare plans to invest approximately $250 million annually towards mergers and acquisitions in the ambulatory space.
• In 2025, the company invested nearly $350 million to expand its portfolio by 35 facilities.
• Tenet added nearly 70 ambulatory surgery centers (ASCs) to its portfolio in 2024 through acquisitions and new facility openings.

Capital Expenditures

• The outlook for capital expenditures in fiscal year 2026 is projected to be between $700 million and $800 million.
• For 2025, the company's capital expenditures guidance was raised to a range of $875 million to $975 million to support growth, including an additional $150 million planned for hospital segment infrastructure upgrades.
• The primary focus of capital expenditures includes supporting the high-acuity strategy, with infrastructure upgrades covering cardiac care units, intensive care units, imaging, cath labs, and surgical programs.